Prelude Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $286k | 75k | 3.81 |
| 2024-03-31 | $320k | 67k | 4.74 |
| 2023-12-31 | $297k | 70k | 4.27 |
| 2023-09-30 | $209k | 68k | 3.09 |
| 2023-06-30 | $107k | 24k | 4.50 |
| 2023-03-31 | $282k | 50k | 5.70 |
| 2022-12-31 | $95k | 16k | 6.04 |
| 2022-06-30 | $232k | 44k | 5.24 |
| 2022-03-31 | $166k | 24k | 6.91 |
| 2021-12-31 | $1.4M | 113k | 12.46 |
| 2021-09-30 | $271k | 8.7k | 31.30 |
| 2021-03-31 | $1.9M | 44k | 43.32 |
| 2020-09-30 | $2.5M | 83k | 30.13 |